Simplifying Global Compliance
FDA Extends Comment Period on Combination Products Rule
Washington Drug Letter
Requests from stakeholders have led the FDA to extend the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing